Literature DB >> 11164190

Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase.

W Zhao1, H Liu, S Xu, F Entschladen, B Niggemann, K S Zänker, R Han.   

Abstract

The biological characteristic cell locomotion and invasion, melanin content, metalloproteinases and telomerase activity were studied in a parental mouse melanoma cell line B16 and two descendents B16BL6 and B16F10. The invasive potential of melanoma cells was assayed in a transwell cell culture chamber. Melanin content was determined by the absorbance value at 470 nm per 10(6) cells. Tumor cells migration within the 3-D collagen matrix was microscopically recorded with a time-lapse video recorder and analyzed by computer-assisted cell tracking. Gelatin zymography was adopted to assay the metalloproteinases secretion. A polymerase chain reaction-based telomeric repeat amplification protocol (TRAP) was used for measuring telomerase activity. The results demonstrated that B16BL6 and B16F10 cells were highly invasive compared to B16 cells, but the melanin content of B16F10 was very low. B16F10 and B16BL6 were hypermotile and secreted much more metalloproteinases than B16. No differences were observed in telomerase activity among the three melanoma cell lines. Invasion of mouse melanoma was closely correlated to tumor cell migration and secretion of metalloproteinases. Melanin content and telomerase activity were phenotypically not related to invasiveness in these three mouse melanoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164190     DOI: 10.1016/s0304-3835(00)00656-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.

Authors:  Zhi-Hui Yang; Shi-Ning Li; Jin-Xing Liu; Qing-Xi Guo; Xing-Wang Sun
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model.

Authors:  Fernando S F Guimarães; Lucas F Andrade; Sharon T Martins; Ana P R Abud; Reginaldo V Sene; Carla Wanderer; Inés Tiscornia; Mariela Bollati-Fogolín; Dorly F Buchi; Edvaldo S Trindade
Journal:  BMC Cancer       Date:  2010-03-25       Impact factor: 4.430

3.  Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice.

Authors:  Ara Parlakian; Iman Gomaa; Sounkary Solly; Ludovic Arandel; Alka Mahale; Gustav Born; Giovanna Marazzi; David Sassoon
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

4.  MMP 9 Gene Promoter Polymorphism in Gastric Cancer.

Authors:  D Krishnaveni; Amar Chand Bhayal; K Sri Manjari; A Vidyasagar; M Uma Devi; M Ramanna; A Jyothy; Pratibha Nallari; A Venkateshwari
Journal:  Indian J Clin Biochem       Date:  2012-04-18

5.  Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice.

Authors:  Wei Xiang; Zhiyuan Ke; Yong Zhang; Grace Ho-Yuet Cheng; Ishak Darryl Irwan; K N Sulochana; Padma Potturi; Zhengyuan Wang; He Yang; Jingyu Wang; Lang Zhuo; R Manjunatha Kini; Ruowen Ge
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

6.  Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma.

Authors:  Javier Cotignola; Boris Reva; Nandita Mitra; Nicole Ishill; Shaokun Chuai; Ami Patel; Shivang Shah; Gretchen Vanderbeek; Daniel Coit; Klaus Busam; Allan Halpern; Alan Houghton; Chris Sander; Marianne Berwick; Irene Orlow
Journal:  BMC Med Genet       Date:  2007-03-08       Impact factor: 2.103

7.  The Role of PPARβ/δ in Melanoma Metastasis.

Authors:  Jonathan Chee Woei Lim; Yuet Ping Kwan; Michelle Siying Tan; Melissa Hui Yen Teo; Shunsuke Chiba; Walter Wahli; Xiaomeng Wang
Journal:  Int J Mol Sci       Date:  2018-09-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.